PEABODY, Mass., March 15, 2016 — Seminex Corp. has added Paul Hartung to its board of directors. Hartung is the former president, CEO and chairman of Cognoptix, where he raised over $32 million in angel and venture capital funding to develop an eye scan for early detection of Alzheimer’s disease, leading the company from concept through clinical trials, with positive Phase 2 results. Hartung has a master’s degree in mechanical engineering from the Massachusetts Institute of Technology and began his career as an advanced manufacturing engineer at General Electric Co. In a former position as director of R&D at Laser Fare Ltd., Hartung developed laser processing techniques for the medical device industry as well as other applications, and while at Trumpf, he developed high power automated laser systems for industrial applications. At Summit Technology, a leading developer of the LASIK procedure, Hartung was responsible for the manufacture of medical laser systems and consumables for vision correction. Seminex designs and manufactures high-power semiconductor lasers for use in military, medical and industrial applications.